| Old Articles: <Older 4431-4440 Newer> |
 |
Pharmaceutical Executive November 1, 2012 Greg Lovas |
The Battle's on for HR Success in China Chinese start-ups have realized that they need to recruit highly skilled and globally oriented general managers from foreign multinationals when they reach a critical size.  |
CRM November 7, 2012 |
The Cloud Changes Everything in Oz Contact centers in Australia will shift to more cloud-based solutions starting in 2015, according to a Frost & Sullivan report.  |
On Wall Street November 1, 2012 Andrew Clark |
The Bright Spot in Chinese Funds Credit conditions in China warrant special attention in light of the country s considerable size and systemic importance to the global economy.  |
On Wall Street October 1, 2012 Milton Ezrati |
Can Japan's Economy Come Back? An aging population and government inaction challenge Japan s faltering economy.  |
Chemistry World September 10, 2012 |
Chinese Drug Makers Accused of Using 'Gutter Oil' Several Chinese drug companies stand accused of manufacturing an antibiotic intermediate using contaminated 'gutter oil', instead of more expensive soybean oil.  |
CFO September 1, 2012 Marielle Segarra |
Business Is Sweet Godiva Chocolatier is enjoying double-digit growth, thanks in part to innovative chocolates and expansion in Asia, says CFO Dave Marberger.  |
Chemistry World September 4, 2012 Andrew Turley |
Kevlar equivalent banned for 20 years A US court has banned Korean company Kolon from manufacturing and marketing its Heracron aramid fiber for 20 years following a long running battle with DuPont, which owns the iconic -- and extremely lucrative -- Kevlar brand.  |
Chemistry World August 28, 2012 Andrew Turley |
Rockwood to pay C$720m for lithium firm US chemicals group Rockwood has struck a deal to buy Talison, an Australian lithium producer with headquarters in Perth. Talison employs 140 people across sites in Australia, Canada, Chile and China.  |
Food Processing August 2012 David Acheson |
Focus on Food Safety: China's New Food Safety Initiatives Five-year plan lacks specific regulations but shows signs of progress.  |
Pharmaceutical Executive August 1, 2012 |
Piramal Pivots for Growth Western drug makers face an unlikely challenge from India's Piramal Healthcare, which has divested its big stake in branded generics for the risky embrace of new drug innovation.  |
| <Older 4431-4440 Newer> Return to current articles. |